Gene Symbol | MITD1 |
---|---|
Entrez Gene | 129531 |
Alt Symbol | - |
Species | Human |
Gene Type | protein-coding |
Description | MIT, microtubule interacting and transport, domain containing 1 |
Other Description | MIT domain-containing protein 1 |
Swissprots | Q8WV92 Q69YV0 |
Accessions | AAX88928 CAH25929 EAX01884 EAX01885 EAX01886 EAX01887 Q8WV92 AK311658 AL161992 CAH10777 BC018453 AAH18453 HQ447338 ADQ31824 XM_011510581 XP_011508883 XM_011510582 XP_011508884 XM_011510583 XP_011508885 XM_011510584 XP_011508886 NM_138798 NP_620153 |
Function | Required for efficient abscission at the end of cytokinesis, together with components of the ESCRT-III complex. {ECO:0000269|PubMed:23015756, ECO:0000269|PubMed:23045692}. |
Subcellular Location | Late endosome membrane; Peripheral membrane protein; Cytoplasmic side. Midbody. Membrane; Peripheral membrane protein; Cytoplasmic side. Note=During cytokinesis, recruited to the midbody via interaction with CHMP1A. Interacts with membranes enriched in phosphoinositides. |
MITD1 Antibody Blocking Peptide - LS-E18955 from LifeSpan Bioscience
|
||||||||||
MITD1 Antibody Blocking Peptide - LS-E18956 from LifeSpan Bioscience
|
||||||||||
MITD1 Blocking Peptide - 33R-7804 from Fitzgerald
|
||||||||||
MITD1 Blocking Peptide - 33R-8509 from Fitzgerald
|
||||||||||
MITD1 fusion protein - Ag11237 from Proteintech Group
|
||||||||||
MITD1 fusion protein - Ag10998 from Proteintech Group
|
||||||||||
Recombinant Human MITD1, His-tagged - MITD1-890H from Creative Biomart
|
||||||||||
Recombinant Human MIT domain-containing protein 1(MITD1) - CSB-YP851970HU CSB-EP851970HU CSB-BP851970HU CSB-MP851970HU from Cusabio
|
||||||||||
MITD1 - TP304503 from Acris Antibodies
|
||||||||||
MITD1 Recombinant Protein Antigen - NBP1-82828PEP from Novus Biologicals
|
||||||||||
MITD1 Protein - NBP2-32721PEP from Novus Biologicals
|
||||||||||
MITD1 Peptide, Human - M34GP09537H from Creative Peptides
|
||||||||||
MIT domain-containing protein 1 (MITD1), Recombinant Protein - MBS1297171 from MyBioSource
|
||||||||||